Clinical Trial Update: A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SI-B001 and SI-B003 in combination with platinum-based chemotherapy as first-line treatment for recurrent or metastatic head a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Platinum-based chemotherapy (unspecified)
• SI-B001
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING